Manayon, Zyque S.

HRN: 21-91-24  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/14/2022
COTRIMOXAZOLE 960MG (TAB)
09/14/2022
09/20/2022
PO
960mg
OD
Immunocompromised State (PCP)
Waiting Final Action 

Indication:  Empiric    Type of Infection:  PneumoniaDisseminated Systemic Infection    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: